Loading...

Home
ETF
PLX

PLX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

PLX News

Protalix BioTherapeutics Q1 2026 Earnings Call Insights

May 13 2026seekingalpha

Protalix BioTherapeutics Reaffirms 2026 Revenue Guidance

May 13 2026seekingalpha

Protalix BioTherapeutics Reports Q1 Earnings

May 13 2026Yahoo Finance

Protalix BioTherapeutics Set to Announce Q1 Earnings on May 13

May 12 2026seekingalpha

Protalix BioTherapeutics Reports FY 2025 Results with Mixed Performance

Mar 19 2026NASDAQ.COM

Protalix BioTherapeutics Q4 2025 Earnings Call Insights

Mar 18 2026seekingalpha

Protalix BioTherapeutics Reports Disappointing Earnings

Mar 18 2026seekingalpha

Protalix BioTherapeutics Earnings Announcement Scheduled

Mar 17 2026seekingalpha

Protalix BioTherapeutics Schedules Financial Results Conference Call

Mar 11 2026Newsfilter

Elfabrio's New Dosing Regimen Approved by EU

Mar 09 2026Globenewswire

Elfabrio's New Dosing Regimen Approved by EU

Mar 09 2026Newsfilter

Ellomay Capital Shareholders Sell Stakes and Board Restructuring

Mar 04 2026Newsfilter

Protalix's New Dosing Regimen Recommended for Approval

Jan 30 2026stocktwits

EMA Endorses New Dosing Regimen for Elfabrio

Jan 30 2026seekingalpha

CHMP Endorses New Treatment Regimen for Fabry Disease

Jan 30 2026Globenewswire

Elfabrio's New Dosing Regimen Receives Positive Opinion from CHMP

Jan 30 2026Globenewswire